SCHEMBL22207201

SCHEMBL22207201

[CH]=CC(O)CCCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
TRPA1 O75762 1/20 0.50
DDAH1 O94760 1/20 0.50
GAPDH P04406 1/20 0.50
FFAR1 O14842 2/20 0.45
FFAR4 Q5NUL3 1/20 0.45
GPR84 Q9NQS5 8/20 0.45
SPHK1 Q9NYA1 2/20 0.45
LMNA P02545 2/20 0.44
CYP2D6 P10635 2/20 0.42
GMNN O75496 1/20 0.42
POLB P06746 1/20 0.42
THPO P40225 1/20 0.42
MTOR P42345 1/20 0.42
BLM P54132 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CETP P11597 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10904527 1.00 MAPT (0.50) MAPTTRPA1DDAH1GAPDHFFAR1
SCHEMBL11517138 1.00 MAPT (0.50) MAPTTRPA1DDAH1GAPDHFFAR1
SCHEMBL3828057 1.00 MAPT (0.50) MAPTTRPA1DDAH1GAPDHFFAR1
SCHEMBL6085231 0.98
SCHEMBL6083215 0.98
SCHEMBL8901304 0.98
SCHEMBL11516038 0.90
SCHEMBL28354972 0.80 TRPA1 (0.65) MAPTTRPA1DDAH1GAPDHFFAR1
SCHEMBL12114194 0.80 TRPA1 (0.65) MAPTTRPA1DDAH1GAPDHFFAR1
SCHEMBL128900 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334373-A1 TRIAZINE BASED ULTRAVOLET ABSORPTION POLYMER BASF SE (DE) 2024-03-13 EP disclosed
CN-117242116-A Triazinyl ultraviolet absorbing polymers 巴斯夫欧洲公司 2023-12-15 CN disclosed
WO-2023213785-A1 UV LIGHT STABILIZERS BASF SE (DE) 2023-11-09 WO disclosed
US-20230088507-A1 TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2023-03-23 US disclosed
US-20230092952-A1 POLYUREA COPOLYMER BASF SE (DE) 2023-03-23 US disclosed
EP-3908576-B1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF SE (DE) 2023-03-08 EP disclosed
CN-114901645-A Triazine UV absorbent and preparation method thereof 巴斯夫欧洲公司 2022-08-12 CN disclosed
CN-114829442-A Polyurea copolymers 巴斯夫欧洲公司 2022-07-29 CN disclosed
US-20220119357-A1 A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF BASF SE (DE) 2022-04-21 US disclosed
EP-3908576-A1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF SE (DE) 2021-11-17 EP disclosed
CN-113260679-A Process for preparing triazine intermediates and process for preparing UV absorbers thereof 巴斯夫欧洲公司 2021-08-13 CN disclosed
CN-113260611-A Method for producing UV absorbers 巴斯夫欧洲公司 2021-08-13 CN disclosed
WO-2021122480-A1 POLYUREA COPOLYMER BASF SE (DE) 2021-06-24 WO disclosed
WO-2020144094-A1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF SE (DE) 2020-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119357-A1 A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF DHPS, NISCH, UNG MAPT 2165/4885TRPA1 1369/4885DDAH1 2505/4885
US-20230088507-A1 TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF NISCH, DHPS, UMPS MAPT 1274/4885TRPA1 732/4885DDAH1 2742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.